Palantir Technologies sees a surge in commercial revenue due to its Artificial Intelligence Platform. The company's US commercial revenue i...

Christmas 2024: Christmas has arrived in the US and the festive season has begun. But in case you are thinking of doing some last minute sh...

Walgreens stocks are showing an unusual movement at the US stock markets, with reports of a possible deal with private equity firm Sycamore...

The broad-based S&P 500 gained 0.2 percent to 5,488.04, while the tech-rich Nasdaq Composite Index advanced 0.3 percent to 17,863.99.

The shift was prompted by Walmart's decision to do a 3-to-1 stock split, which will reduce its stock's weighting in the index. The Dow is a...

Adding Amazon will increase consumer retail exposure as well as other areas in the Dow, and the move was prompted by Walmart's decision to ...

Walgreens Boots Alliance has been holding early talks about ways to separate Boots, which could be valued at about £7 billion ($8.8 billion...

At 10:07 a.m. ET, the Dow Jones Industrial Average was up 267.99 points, or 0.80%, at 33,968.27, the S&P 500 was up 19.71 points, or 0.50%,...

Pessina stepped down from this role in 2020 but continued as executive chairman of Walgreens Boots Alliance Inc. which owns the chemist cha...

Reliance and Apollo have been in dialogue with global banks and financial institutions to stitch together funding for what would arguably b...

The Dow Jones Industrial Average rose 90.42 points, or 0.25%, to 36,488.63, the S&P 500 gained 6.71 points, or 0.14%, to 4,793.06 and the N...

While Viatris has commercialisation rights for the US, Canada, Australia, EU and others, Biocon will be able to commercialise the products ...

The shares were little changed at $12.99 as of 9:59 am Wednesday, hovering around levels not seen since 2009.

“I’m a bit worried about the valuation of these very popular companies,” Robert Naess said.

Shanghvi is the third richest in the global healthcare industry after Ernesto Bertarelli.

Five big retailers led by Walgreen have sued Pfizer and Ranbaxy for allegedly delaying launch of the Indian company's low-cost version of L...

Chandigarh-based Surya Pharmaceuticals today said its subsidiary has acquired US-based over-the-counter analgesic drug manufacturer ActivOn...